Clinical Trials Browser

Interventional × Hemophilia A × Clear all

NCT06752850 2025-12-19

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Phase 4 Active not recruiting

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT03020160 2023-01-11

HAVEN 4

Phase 3 Completed

48 enrolled 44 charts 1 FDA

Classical hematology

Hemophilia A

NCT02847637 2022-11-16

HAVEN 3

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

NCT02622321 2021-06-24

HAVEN 1

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

NCT02795767 2021-06-02

HAVEN 2

Phase 3 Completed

88 enrolled 65 charts 1 FDA

Classical hematology

Hemophilia A

NCT00127543 2021-01-05

Kid Cards: Teaching Kids About Medicines

Phase NA Withdrawn

Classical hematology

Anemia, Sickle Cell, Blood Coagulation Disorders, Hemophilia A, Neoplasms

NCT03237273 2017-08-02

HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound

Phase NA Unknown

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular

NCT02999308 2016-12-21

CHIPS

Phase 4 Unknown

Classical hematology

Hemophilia A

NCT01105923 2015-02-02

MAPLE

Phase NA Unknown

BreastClassical hematologyHead & Neck

Anemia, Sickle Cell, Asthma, Attention Deficit Disorder with Hyperactivity, Bone Diseases, Metabolic, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Glaucoma, Heart Failure, Hemophilia A, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

NCT00037544 2008-04-22

Study Evaluating ReFacto AF in Severe Hemophilia A

Phase 3 Completed

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular